115 related articles for article (PubMed ID: 29771422)
1. Has-MiR-196a-2 is up-regulated and acts as an independent unfavorable prognostic factor in thyroid carcinoma.
Fu YT; Zhang DQ; Zhou L; Li SJ; Sun H; Liu XL; Zheng HB
Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2707-2714. PubMed ID: 29771422
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of microRNA-196a predicts poor prognosis in human ovarian carcinoma.
Fan Y; Fan J; Huang L; Ye M; Huang Z; Wang Y; Li Q; Huang J
Int J Clin Exp Pathol; 2015; 8(4):4132-7. PubMed ID: 26097603
[TBL] [Abstract][Full Text] [Related]
3. MiR-9 and miR-21 as prognostic biomarkers for recurrence in papillary thyroid cancer.
Sondermann A; Andreghetto FM; Moulatlet AC; da Silva Victor E; de Castro MG; Nunes FD; Brandão LG; Severino P
Clin Exp Metastasis; 2015 Aug; 32(6):521-30. PubMed ID: 26007293
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of hsa-miR-196a-5p is associated with MIR196A2 methylation and affects the malignant biological behaviors of glioma.
Qu S; Qiu O; Huang J; Liu J; Wang H
Genomics; 2021 May; 113(3):1001-1010. PubMed ID: 33636314
[TBL] [Abstract][Full Text] [Related]
5. High miR-196a and low miR-367 cooperatively correlate with unfavorable prognosis of high-grade glioma.
Guan Y; Chen L; Bao Y; Qiu B; Pang C; Cui R; Wang Y
Int J Clin Exp Pathol; 2015; 8(6):6576-88. PubMed ID: 26261539
[TBL] [Abstract][Full Text] [Related]
6. [Expression of microRNA-221 and IL-17 in papillary thyroid carcinoma and correlation with clinicopathologic features].
Jiang XL; Zhang H; Chen YL; Peng L
Zhonghua Bing Li Xue Za Zhi; 2017 Mar; 46(3):160-165. PubMed ID: 28297755
[No Abstract] [Full Text] [Related]
7. miR-196a-2 Promotes Malignant Progression of Thyroid Carcinoma by Targeting NRXN1.
Fan Y; Fei M; Li Y; Gao Z; Zhu Y; Dai G; Wu D
Comput Math Methods Med; 2021; 2021():4856820. PubMed ID: 34158819
[TBL] [Abstract][Full Text] [Related]
8. Association of miR-193b down-regulation and miR-196a up-regulation with clinicopathological features and prognosis in gastric cancer.
Mu YP; Tang S; Sun WJ; Gao WM; Wang M; Su XL
Asian Pac J Cancer Prev; 2014; 15(20):8893-900. PubMed ID: 25374225
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of upregulation of mir-196a-5p in gastric cancer and enriched KEGG pathway analysis of target genes.
Li HL; Xie SP; Yang YL; Cheng YX; Zhang Y; Wang J; Wang Y; Liu DL; Chen ZF; Zhou YN; Wu HY
Asian Pac J Cancer Prev; 2015; 16(5):1781-7. PubMed ID: 25773825
[TBL] [Abstract][Full Text] [Related]
10. Prognostic implications of miR-146b expression and its functional role in papillary thyroid carcinoma.
Chou CK; Yang KD; Chou FF; Huang CC; Lan YW; Lee YF; Kang HY; Liu RT
J Clin Endocrinol Metab; 2013 Feb; 98(2):E196-205. PubMed ID: 23264400
[TBL] [Abstract][Full Text] [Related]
11. MiR-20b Displays Tumor-Suppressor Functions in Papillary Thyroid Carcinoma by Regulating the MAPK/ERK Signaling Pathway.
Hong S; Yu S; Li J; Yin Y; Liu Y; Zhang Q; Guan H; Li Y; Xiao H
Thyroid; 2016 Dec; 26(12):1733-1743. PubMed ID: 27717302
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-196a/-196b promote cell metastasis via negative regulation of radixin in human gastric cancer.
Tsai MM; Wang CS; Tsai CY; Chen CY; Chi HC; Tseng YH; Chung PJ; Lin YH; Chung IH; Chen CY; Lin KH
Cancer Lett; 2014 Sep; 351(2):222-31. PubMed ID: 24933454
[TBL] [Abstract][Full Text] [Related]
13. MiRNA-146b-5p upregulates migration and invasion of different Papillary Thyroid Carcinoma cells.
Lima CR; Geraldo MV; Fuziwara CS; Kimura ET; Santos MF
BMC Cancer; 2016 Feb; 16():108. PubMed ID: 26883911
[TBL] [Abstract][Full Text] [Related]
14. New global analysis of the microRNA transcriptome of primary tumors and lymph node metastases of papillary thyroid cancer.
Saiselet M; Gacquer D; Spinette A; Craciun L; Decaussin-Petrucci M; Andry G; Detours V; Maenhaut C
BMC Genomics; 2015 Oct; 16():828. PubMed ID: 26487287
[TBL] [Abstract][Full Text] [Related]
15. Associations of miR-146a and miR-146b expression and clinical characteristics in papillary thyroid carcinoma.
Sun M; Fang S; Li W; Li C; Wang L; Wang F; Wang Y
Cancer Biomark; 2015; 15(1):33-40. PubMed ID: 25524940
[TBL] [Abstract][Full Text] [Related]
16. Hsa-miR-139-5p is a prognostic thyroid cancer marker involved in HNRNPF-mediated alternative splicing.
Montero-Conde C; Graña-Castro O; Martín-Serrano G; Martínez-Montes ÁM; Zarzuela E; Muñoz J; Torres-Perez R; Pita G; Cordero-Barreal A; Leandro-García LJ; Letón R; López de Silanes I; Guadalix S; Pérez-Barrios A; Hawkins F; Guerrero-Álvarez A; Álvarez-Escolá C; Regojo-Zapata RM; Calsina B; Remacha L; Roldán-Romero JM; Santos M; Lanillos J; Jordá M; Riesco-Eizaguirre G; Zafon C; González-Neira A; Blasco MA; Al-Shahrour F; Rodríguez-Antona C; Cascón A; Robledo M
Int J Cancer; 2020 Jan; 146(2):521-530. PubMed ID: 31403184
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-222 Promotes Invasion and Metastasis of Papillary Thyroid Cancer Through Targeting Protein Phosphatase 2 Regulatory Subunit B Alpha Expression.
Huang Y; Yu S; Cao S; Yin Y; Hong S; Guan H; Li Y; Xiao H
Thyroid; 2018 Sep; 28(9):1162-1173. PubMed ID: 29882471
[TBL] [Abstract][Full Text] [Related]
18. miR-146a and miR-146b in the diagnosis and prognosis of papillary thyroid carcinoma.
Qiu Z; Li H; Wang J; Sun C
Oncol Rep; 2017 Nov; 38(5):2735-2740. PubMed ID: 29048684
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA GAS5 suppresses triple negative breast cancer progression through inhibition of proliferation and invasion by competitively binding miR-196a-5p.
Li S; Zhou J; Wang Z; Wang P; Gao X; Wang Y
Biomed Pharmacother; 2018 Aug; 104():451-457. PubMed ID: 29793177
[TBL] [Abstract][Full Text] [Related]
20. The PDCD4/miR-21 pathway in medullary thyroid carcinoma.
Pennelli G; Galuppini F; Barollo S; Cavedon E; Bertazza L; Fassan M; Guzzardo V; Pelizzo MR; Rugge M; Mian C
Hum Pathol; 2015 Jan; 46(1):50-7. PubMed ID: 25316501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]